CDC Guidance

Item Date Updated
Infection Prevention
Interim US Guidance for Risk Assessment and Public Health Management of Persons with Potential COVID-19 Exposures: Geographic Risk and Contacts of Laboratory-confirmed Cases 5/3
Steps Healthcare Facilities Can Take Now to Prepare for Coronavirus Disease 2019 3/20
Preparing for COVID-19 in Nursing Homes 6/22
Interim US Guidance for Risk Assessment and Public Health Management of Healthcare Personnel with Potential Exposure in a Healthcare Setting to Patients with COVID-19 6/18
Healthcare Infection Prevention and Control FAQs for COVID-19 6/5
Infection Control Guidance for Healthcare Professionals about Coronavirus 6/3
Alternative Care Sites: Guidance for critical infection prevention and control considerations for alternative care sites. 4/24
COVID-19 Outpatient Dialysis Facility Preparedness Assessment Tool: Highlights recommended areas for outpatient dialysis facilities, which hospitals should review in preparation for the potential arrivals of COVID-19 patients. 3/26
Considerations for Inpatient Obstetric Healthcare Settings 4/6
Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Healthcare Settings 6/19
Guidance for Direct Service Providers 6/28
Interim Additional Guidance for Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Outpatient Hemodialysis Facilities 8/24
What Healthcare Personnel Should Know about Caring for Patients with Confirmed or Possible COVID-19 Infection 6/1
Interim Clinical Guidance for Management of Patients with Confirmed 2019 Novel Coronavirus Infection 6/2
Information for Clinicians on Therapeutic Options for COVID-19 Patients: Information on three drugs currently being studied in the US to treat COVID-19; two have been FDA-approved for other purposes (chloroquine and hydroxychloroquine) and the third is an investigational agent (remdesivir) 4/25
Interim Guidance on Management of COVID-19 in Correctional and Detention Facilities 5/7
Severe Illness Associated with Using Non-Pharmaceutical Chloroquine Phosphate to Prevent and Treat COVID-19: Address cases of individuals ingesting non-pharmaceutical chloroquine phosphate, which can cause health consequences, including death. Clinicians and public health officials should discourage the public from this behavior and advise that chloroquine and the related compound hydroxychloroquine should be used only under the supervision of a health care provider as prescribed medications. 3/27
Human Infection with 2019 Novel Coronavirus Person Under Investigation (PUI) and Case Report Form
Clinical Questions about COVID-19: Questions and Answers 6/4
Considerations for Providing Hemodialysis to Patients with Suspected or Confirmed COVID-19 in Acute Care Settings 4/17
Clinical Care Guidance for Healthcare Professionals about COVID-19 6/1
Treatment – Pediatrics
Information for Pediatric Healthcare Providers 5/29
Evaluation and Management Considerations for Neonates At Risk for COVID-19 5/20
Discontinuation of Isolation for Persons with COVID -19 Not in Healthcare Settings 5/29
Discontinuation of Transmission-Based Precautions and Disposition of Patients with COVID-19: clarifies that patients with COVID-19 can be discharged whenever clinically indicated, updates guidance for a test-based strategy from two swabs to one, and adds guidance for discontinuation of transmission-based precautions without testing, discontinuation of empiric transmission-based precautions for patients suspected of having COVID-19, and when a testing-based strategy for discontinuation of transmission-based precautions is preferred. 5/2
Symptom-Based Strategy to Discontinue Isolation for Persons with COVID-19: recommends that isolation be maintained for at least 10 days after illness onset and at least three days (72 hours) after recovery 5/3
Key Considerations for Transferring Patients to Relief Healthcare Facilities when Responding to Community Transmission of COVID-19 in the United States 7/30

NYS DOH Guidance

Item Date Updated
Infection Prevention
COVID-19 Guidance for Hospital Operators Regarding Visitation: Effective immediately, all hospitals suspend visitation except when medically necessary (i.e., a visitor is essential to the care of the patient) or for family members or legal representatives of patients in imminent end-of-life situations 3/18
PUI Guidance: Responding to the revised CDC criteria, DOH issued updated PUI guidance 3/6
Dear Administrator Letter: Addresses questions sent to DOH on infection control measures, health care delivery for asymptomatic persons under monitoring, and management of health care personnel with potential exposure in a health care setting 2/25
Ensuring Access to Health Care Services During COVID-19: Advises health care providers to continue to ensure infection prevention and control measures are in place and to contact patients who may have missed routine care or follow-up appointments during the COVID-19 public health emergency; outlines strategies to separate well individuals from the sick and reduce transmission among health care personnel, and best practices for contacting patients. 5/19
Hospital Access to Hydroxychloroquine and Azithromycin for the Treatment of COVID-19: DOH is working collaboratively with health care practitioners who are treating certain patients hospitalized with COVID-19 to implement scientific studies and research on the efficacy and tolerability of Hydroxylchloroquine and Azithromycin. This Health Advisory outlines conditions of participation in the state-approved, FDA-authorized clinical study. 3/25
DOH Advisory on Pediatric Inflammatory Disease Potentially Related to COVID-19: reports that hospitals must immediately report cases of Pediatric Multi-System Inflammatory Syndrome potentially associated with COVID-19 in patients who are under 21 years of age via the Health Emergency Response Data System (HERDS) application on the health commerce system. Hospitals also must perform a diagnostic and serological test to detect the presence of SARS-COV-2, the virus that causes COVID-19, or corresponding antibodies in the patient. 5/6
Health Advisory: Provides an interim case definition for Pediatric Multi-System Inflammatory Syndrome Temporally Associated with COVID-19. The Advisory identifies clinical, general laboratory, virologic laboratory, and epidemiologic criteria for case classification. 5/13
Multisystem Inflammatory Syndrome in Children (MIS-C): Guidance for Ambulatory Care Providers 6/24
Bureau of Early Intervention Guidance to Early Intervention Providers Regarding COVID-19 9/22
COVID-19 Release from Home Isolation: Revised to follow the CDC’s non-test-based strategy 3/28
Discontinuation of Isolation for Patients with COVID-19 Who Are Hospitalized or in Nursing Homes, Adult Care Homes, or Other Congregate Settings with Vulnerable Residents: Recommends discontinuation of transmission-based precautions for patients with COVID-19 in these settings when they meet more stringent conditions compared to recent guidance. 4/19

NJ DOH Guidance

NYC DOHMH Guidance

Item Date Updated
Infection Prevention
COVID-19 Outpatient Infection Control Quick Guide 3/16
Guidance for people with increased risk of severe COVID-19 3/8
DOH Commissioner order to all educators, first responders, and health care workers employed by NYC 3/5
2019 Novel Coronavirus Local Health Department Guidance: Isolation and Quarantine (Please note this items is written for use by local health departments and is being shared with members for informational purposes only) 2/5
Interim Movement and Monitoring Guidance for Asymptomatic Persons with Potential Exposure to the 2019 Novel Coronavirus (Please note this items is written for use by local health departments and is being shared with members for informational purposes only) 2/5
Summary of Current New York City COVID-19 Guidance for Quarantine, Isolation and Transmission-Based Precautions: examines guidance for non-hospitalized people, including most essential and health care personnel, hospitalized people, immunocompromised people in any setting, residents of long-term care and other congregate living facilities with vulnerable populations, employees of nursing homes and adult care facilities, a person in quarantine due to close contact with someone who has a positive COVID-19 diagnosis, and quarantine or exclusion of health care personnel with exposure at work to a person with a positive COVID-19 diagnostic test. 6/28
Health Care Provider Management Checklist for Patients Suspected to Have COVID-19 2/28
FAQ About 2019 Novel Coronavirus and COVID-19 for Health Care Providers 6/29
Identifying and Triaging Adult Patients at Increased Risk for Severe COVID-19 in Outpatient Settings 7/30
Health Advisory #14: Outlines recommendations for the discontinuation of isolation and monitoring for people who are asymptomatic; isolation and transmission-based precautions for people with COVID-19, including non-hospitalized patients; residents and patients in special settings; and people who are immunocompromised 5/14

CMS Guidance

SONPM National Registry on Infant COVID-19 Infection

The American Academy of Pediatrics Section on Neonatal and Perinatal Medicine (SONPM) is inviting all hospitals that care for infants to participate in a National Perinatal COVID-19 registry by submitting deidentified maternal and neonatal data pertaining to COVID-19. The study aims to gather data to determine the risk of transplacental, perinatal, and post-natal transmission of COVID-19. For more information on the registry, data collected, and how to participate, please contact Mark Hudak, MD, FAAP.

ASPR Guidance on Using CHEMPACK Assets

The US Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) has issued guidance on the use of CHEMPACK assets during the COVID-19 pandemic.

Public Health and Health Planning Council Regulations

New York State’s Public Health and Planning Council released regulations on March 10 clarifying requirements for isolation and quarantine, and updating other areas of the code applicable to local health departments and hospitals during a communicable disease outbreak.

American College of Cardiology Guidance for the Cardiovascular Care Team

The American College of Cardiology released a clinical bulletin containing COVID-19 guidance for the cardiovascular care team. The bulletin contains current COVID-19 clinical context, acute cardiac complications, implications for patients with underlying cardiovascular conditions, and cardiac-specific preparedness recommendations.

ACOG Clinical Updates

The American College of Obstetricians and Gynecologists (ACOG) has collated resources for clinicians treating pregnant COVID-19 patients. Recent updates include updated guidance on frequently asked questions around personal protective equipment (PPE) and pregnant staff members, and how to manage the second stage of labor. A recording of the March 30 joint ACOG and New York State Perinatal Quality Collaborative webinar featuring State faculty discussing treatment protocols and best practices for pregnant COVID-19 patients is available here.